Summit Therapeutics (SMMT) Short Interest Ratio & Short Volume $18.62 -1.38 (-6.90%) (As of 11/20/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Summit Therapeutics Short Interest DataSummit Therapeutics (SMMT) has a short interest of 17.04 million shares. This marks a 10.29% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.4, indicating that it would take 3.4 days of the average trading volume of 2.10 million shares to cover all short positions.Current Short Interest17,040,000 sharesPrevious Short Interest15,450,000 sharesChange Vs. Previous Month+10.29%Dollar Volume Sold Short$316.77 millionShort Interest Ratio3.4 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares737,450,000 sharesPercentage of Shares Shorted2.31%Today's Trading Volume1,780,363 sharesAverage Trading Volume2,095,534 sharesToday's Volume Vs. Average85% Short Selling Summit Therapeutics? Sign up to receive the latest short interest report for Summit Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSMMT Short Interest Over TimeSMMT Days to Cover Over TimeSMMT Percentage of Float Shorted Over Time Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. Summit Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202417,040,000 shares $316.77 million +10.3%N/A3.4 $18.59 10/15/202415,450,000 shares $337.43 million -5.5%N/A3.1 $21.84 9/30/202416,340,000 shares $357.85 million -21.2%N/A3.3 $21.90 9/15/202420,730,000 shares $661.91 million +13.7%N/A4.5 $31.93 8/31/202418,230,000 shares $236.63 million +5.6%N/A5.5 $12.98 8/15/202417,260,000 shares $204.88 million -3.0%20.1%4.3 $11.87 Get the Latest News and Ratings for SMMT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Summit Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/202417,790,000 shares $192.13 million -4.5%20.7%4.4 $10.80 7/15/202418,630,000 shares $176.43 million -8.3%22.4%4.5 $9.47 6/30/202420,310,000 shares $158.42 million -13.3%24.4%5.1 $7.80 6/15/202423,430,000 shares $196.58 million +10.2%28.2%5.8 $8.39 5/31/202421,260,000 shares $184.64 million -5.8%25.6%5.2 $8.69 5/15/202422,570,000 shares $101.34 million -3.6%27.2%10.1 $4.49 4/30/202423,400,000 shares $91.96 million +2.2%28.2%10.3 $3.93 4/15/202422,900,000 shares $83.70 million +5.0%27.6%10.1 $3.66 3/31/202421,810,000 shares $90.29 million +28.6%26.3%9.3 $4.14 3/15/202416,960,000 shares $78.36 million +6.3%20.4%7.6 $4.62 2/29/202415,950,000 shares $72.41 million +25.1%19.2%8.2 $4.54 2/15/202412,750,000 shares $59.54 million +12.8%15.5%6.9 $4.67 1/31/202411,300,000 shares $44.30 million +4.4%N/A7.1 $3.92 1/15/202410,820,000 shares $33.54 million +10.5%N/A8.3 $3.10 12/31/20239,790,000 shares $25.55 million +3.7%N/A8.2 $2.61 12/15/20239,440,000 shares $24.17 million -6.0%N/A8.9 $2.56 11/30/202310,040,000 shares $20.38 million +0.4%N/A10.4 $2.03 11/15/202310,000,000 shares $19.80 million +5.5%N/A10.9 $1.98 10/31/20239,480,000 shares $18.39 million -11.4%N/A9.3 $1.94 10/15/202310,700,000 shares $17.98 million -0.1%N/A10.3 $1.68 9/30/202310,710,000 shares $20.03 million +1.1%N/A10.6 $1.87 9/15/202310,590,000 shares $19.80 million +0.6%N/A9.5 $1.87 8/31/202310,530,000 shares $17.06 million -9.1%N/A6.2 $1.62 8/15/202311,580,000 shares $22.23 million +7.0%N/A6.4 $1.92 7/31/202310,820,000 shares $22.72 million +7.8%N/A5.7 $2.10 7/15/202310,040,000 shares $21.49 million -2.1%N/A5 $2.14 6/30/202310,250,000 shares $25.73 million +82.1%N/A5.1 $2.51 6/15/20235,630,000 shares $11.26 million +23.2%N/A2.7 $2.00 5/31/20234,570,000 shares $7.45 million -12.3%N/A2.5 $1.63 5/15/20235,210,000 shares $9.53 million +2.8%N/A2.5 $1.83 4/30/20235,070,000 shares $6.69 million +8.8%15.2%2.4 $1.32 4/15/20234,660,000 shares $7.32 million +18.6%N/A2 $1.57 3/31/20233,930,000 shares $6.88 million -16.2%N/A1.5 $1.75 3/15/20234,690,000 shares $7.69 million -22.1%N/A1.3 $1.64Tesla Execs are Freaking Out (Ad)It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.Click here to get the details. 2/28/20236,020,000 shares $10.84 million +11.7%21.7%0.6 $1.80 2/15/20235,390,000 shares $12.45 million +25.6%19.4%0.6 $2.31 1/31/20234,290,000 shares $15.23 million +9.7%15.4%0.4 $3.55 1/15/20233,910,000 shares $18.77 million -1.3%14.1%0.4 $4.80 12/30/20223,960,000 shares $16.83 million -21.4%14.3%0.5 $4.25 12/15/20225,040,000 shares $18.04 million +2,045.6%18.1%0.6 $3.58 11/30/2022234,900 shares $187,920.00 -10.0%0.8%0 $0.80 11/15/2022260,900 shares $284,381.00 -6.0%0.9%0.5 $1.09 10/31/2022277,600 shares $302,584.00 -25.9%2.0%0.1 $1.09 10/15/2022374,700 shares $434,652.00 +26.8%2.7%0.2 $1.16 9/30/2022295,400 shares $351,526.00 +45.7%2.2%0.1 $1.19 9/15/2022202,700 shares $281,753.00 -42.4%1.5%0.1 $1.39 8/31/2022351,600 shares $421,920.00 -58.4%2.6%0.2 $1.20 8/15/2022845,800 shares $896,548.00 -3.1%6.2%0.5 $1.06 7/31/2022872,400 shares $881,124.00 -0.8%3.4%5.1 $1.01 7/15/2022879,200 shares $967,120.00 +15.6%3.4%5.1 $1.10 6/30/2022760,800 shares $760,800.00 -31.5%3.0%4.3 $1.00 6/15/20221,110,000 shares $1.10 million +0.9%4.3%6.3 $0.99 5/31/20221,100,000 shares $1.46 million -28.1%4.3%10 $1.33 5/15/20221,530,000 shares $1.73 million +12.5%6.0%14 $1.13 4/30/20221,360,000 shares $2.16 million +19.3%5.3%11.8 $1.59 4/15/20221,140,000 shares $2.47 million +3.6%4.4%9.3 $2.17 3/31/20221,100,000 shares $2.70 million -8.3%4.3%8.7 $2.45 3/15/20221,200,000 shares $3.32 million No Change4.7%6.2 $2.77 2/28/20221,200,000 shares $3.29 million +13.2%4.8%5.9 $2.74 2/15/20221,060,000 shares $2.14 million +50.2%4.2%5.2 $2.02 1/31/2022705,800 shares $1.55 million +98.0%2.8%3.6 $2.20 1/15/2022356,500 shares $852,035.00 -31.3%1.4%1.9 $2.39 12/31/2021518,700 shares $1.40 million +0.8%2.1%3 $2.69 12/15/2021514,600 shares $2.44 million +26.3%2.0%3 $4.75 11/30/2021407,300 shares $2.07 million +5.0%1.6%2.8 $5.08 11/15/2021387,900 shares $2.02 million -7.7%1.6%2.5 $5.20 10/29/2021420,300 shares $2.17 million -22.3%1.7%2.7 $5.16 10/15/2021540,600 shares $2.78 million -14.3%2.2%3.4 $5.15 9/30/2021630,800 shares $3.16 million +17.8%2.5%3.7 $5.01 9/15/2021535,600 shares $3.45 million +11.4%2.1%2.5 $6.44 8/31/2021480,700 shares $3.83 million -30.2%1.9%2.3 $7.97 8/13/2021688,600 shares $5.45 million -18.6%2.8%3.1 $7.92 7/30/2021845,900 shares $6.20 million +14.9%4.0%3 $7.33 7/15/2021736,000 shares $5.17 million -9.2%3.5%2.6 $7.03 6/30/2021810,500 shares $6.05 million +104.5%3.8%3 $7.46 6/15/2021396,300 shares $2.60 million -20.3%1.9%1.7 $6.56 5/28/2021496,900 shares $3.89 million +1.3%4.7%2.4 $7.82 5/14/2021490,400 shares $2.66 million +13.8%4.7%2.5 $5.43 4/30/2021431,100 shares $2.69 million -35.9%2.0%2.4 $6.25 4/15/2021672,300 shares $3.74 million +49.3%3.0%3.3 $5.56 3/31/2021450,400 shares $2.52 million +17.3%2.1%2.1 $5.60 3/15/2021384,100 shares $2.49 million +4.6%1.8%1.6 $6.47 2/26/2021367,200 shares $2.56 million +26.6%1.7%1.4 $6.97 2/12/2021290,000 shares $2.14 million -26.1%1.3%1.2 $7.37Tesla Execs are Freaking Out (Ad)It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.Click here to get the details. 1/29/2021392,500 shares $2.70 million -2.6%1.8%1.5 $6.87 1/15/2021402,800 shares $2.13 million +0.7%1.9%1.8 $5.29 12/31/2020400,200 shares $2.01 million +14,722.2%1.9%2.1 $5.02 12/15/20202,700 shares $14,256.00 -87.0%0.0%0 $5.28 11/30/202020,700 shares $89,838.00 -64.3%0.1%0.2 $4.34 11/15/202058,000 shares $281,300.00 +14.2%0.3%0.6 $4.85 10/30/202050,800 shares $168,656.00 -38.0%0.2%1.1 $3.32 10/15/202081,900 shares $287,469.00 +30.2%0.4%1.5 $3.51 9/30/202062,900 shares $216,376.00 -6.5%N/A1 $3.44 9/15/202067,300 shares $218,725.00 +27.2%N/A1.1 $3.25 8/31/202052,900 shares $182,505.00 -7.2%N/A0.7 $3.45 8/14/202057,000 shares $192,090.00 -71.1%N/A0.7 $3.37 7/31/2020197,000 shares $713,140.00 +93.1%N/A1.9 $3.62 7/15/2020102,000 shares $328,440.00 +74.1%N/A0.9 $3.22 6/30/202058,600 shares $178,144.00 +30.5%N/A0.3 $3.04 6/15/202044,900 shares $156,701.00 -3.9%N/A0.2 $3.49 5/29/202046,700 shares $187,267.00 +156.6%N/A0.2 $4.01 5/15/202018,200 shares $60,424.00 -77.6%N/A0.1 $3.32 4/30/202081,200 shares $304,500.00 +2,220.0%N/A0.4 $3.75 4/15/20203,500 shares $14,140.00 -84.7%N/A0 $4.04 3/31/202022,900 shares $84,272.00 -87.4%N/A0.3 $3.68 3/13/2020181,200 shares $483,804.00 -56.5%N/A2.2 $2.67 2/28/2020416,600 shares $858,196.00 -20.3%N/A7.3 $2.06 2/14/2020522,400 shares $888,080.00 -25.1%N/A11 $1.70 1/31/2020697,400 shares $983,334.00 +2.5%N/A16.8 $1.41 1/15/2020680,300 shares $1.07 million +7.5%N/A20.8 $1.58 12/31/2019632,900 shares $993,653.00 -7.1%N/A16.3 $1.57 SMMT Short Interest - Frequently Asked Questions What is Summit Therapeutics' current short interest? Short interest is the volume of Summit Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 17,040,000 shares of SMMT short. Learn More on Summit Therapeutics' current short interest. What is a good short interest ratio for Summit Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SMMT shares currently have a short interest ratio of 3.0. Learn More on Summit Therapeutics's short interest ratio. Which institutional investors are shorting Summit Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Summit Therapeutics: Jane Street Group LLC, Wolverine Trading LLC, PEAK6 Investments LLC, LMR Partners LLP, and Belvedere Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Summit Therapeutics' short interest increasing or decreasing? Summit Therapeutics saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 17,040,000 shares, an increase of 10.3% from the previous total of 15,450,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Summit Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Summit Therapeutics: Takeda Pharmaceutical Company Limited (0.19%), BioNTech SE (0.84%), Teva Pharmaceutical Industries Limited (1.60%), BeiGene, Ltd. (1.12%), Viatris Inc. (2.09%), Moderna, Inc. (10.02%), Genmab A/S (0.37%), Dr. Reddy's Laboratories Limited (1.28%), Vaxcyte, Inc. (7.16%), Catalent, Inc. (4.65%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Summit Therapeutics stock? Short selling SMMT is an investing strategy that aims to generate trading profit from Summit Therapeutics as its price is falling. SMMT shares are trading down $1.38 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Summit Therapeutics? A short squeeze for Summit Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SMMT, which in turn drives the price of the stock up even further. How often is Summit Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SMMT, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Takeda Pharmaceutical Short Squeeze BioNTech Short Squeeze Teva Pharmaceutical Industries Short Squeeze BeiGene Short Squeeze Viatris Short Squeeze Moderna Short Squeeze Genmab A/S Short Squeeze Dr. Reddy's Laboratories Short Squeeze Vaxcyte Short Squeeze Catalent Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SMMT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Summit Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Summit Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SMMT Stock Alerts